PROCEPT BioRobotics (PRCT) Price to Sales (2021 - 2026)

PROCEPT BioRobotics (PRCT) has reported Price to Sales for 6 consecutive years, with 13.68 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Sales fell 66.17% year-over-year to 13.68 in Q2 2026; TTM through Jun 2026 was 3.83, a 67.09% decrease from a year earlier, with the FY2025 full-year figure at 5.75, down 70.69% from the prior year.
• Price to Sales was 13.68 for Q2 2026 at PROCEPT BioRobotics, down from 17.12 in the prior quarter.
• Over five years, Price to Sales peaked at 108.63 in Q1 2022 and troughed at 13.68 in Q2 2026.
• A 5-year average of 54.42 and a median of 50.6 in 2023 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales jumped 92.64% in 2022 and plunged 66.57% in 2025, its largest moves.
• Over 5 years, Price to Sales stood at 78.32 in 2022, then plunged by 37.66% to 48.82 in 2023, then surged by 32.25% to 64.57 in 2024, then plunged by 64.07% to 23.2 in 2025, then slumped by 41.03% to 13.68 in 2026.
• The last three Price to Sales figures came in at 13.68 (Q2 2026), 17.12 (Q1 2026), and 23.2 (Q4 2025), per Business Quant data.